Skip to content
Screener

Bruker BRKR Other income, net (Note 6)

Other income, net (Note 6) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$31M
Danaher logo
DanaherDHR
-$3M+92.9%
WAT
Waters CorporationWAT
$1M0.0%
908 Devices logo
908 DevicesMASS
-$7K+78.8%
TEC
Bio-TechneTECH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.81B+67.9%
Enterprise value$9.45B+35.1%
P/S2.2×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other charges, net13.214.439.451.3
Total operating expenses481.3346.0850.9705.4
Operating (loss) income(65.3)11.9(55.1)43.7
Interest and other income (expense), net24.6(11.4)36.3(18.1)
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries(40.7)0.5(18.8)25.6
Income tax provision (benefit)14.2(3.1)16.75.6
Equity in income of unconsolidated investees, net of tax4.00.60.31.0
Consolidated net (loss) income(50.9)4.2(35.2)21.0

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's other income, net (note 6)?
Bruker (BRKR) reported other income, net (note 6) of $24.6M in Q2 2026.
How has Bruker's other income, net (note 6) changed year-over-year?
Bruker's other income, net (note 6) increased by 315.8% year-over-year, from -$11.4M to $24.6M.
What is the long-term trend for Bruker's other income, net (note 6)?
Over 4 years (2021 to 2025), Bruker's other income, net (note 6) has grown at a 23.7% compound annual growth rate (CAGR), from -$19.7M to -$46.2M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Bruker's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude